Massachusetts Financial Services’s Sana Biotechnology SANA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-57,411	Closed	-$239K	–	921
2024 Q3	$239K	Sell	57,411 -1,390	-2%	-$7.3K	﹤0.01%	836
2024 Q2	$321K	Sell	58,801 -180,030	-75%	-$1.43M	﹤0.01%	840
2024 Q1	$2.39M	Sell	238,831 -814,499	-77%	-$6.1M	﹤0.01%	723
2023 Q4	$4.3M	Sell	1,053,330 -6,810	-0.6%	-$25.1K	﹤0.01%	670
2023 Q3	$4.1M	Sell	1,060,140 -8,047	-0.8%	-$43.3K	﹤0.01%	670
2023 Q2	$6.37M	Sell	1,068,187 -14,257	-1%	-$82.2K	﹤0.01%	634
2023 Q1	$3.54M	Buy	1,082,444 +29,872	+3%	+$119K	﹤0.01%	665
2022 Q4	$4.16M	Buy	1,052,572 +234,549	+29%	+$1.15M	﹤0.01%	666
2022 Q3	$4.91M	Buy	818,023 +55,407	+7%	+$400K	﹤0.01%	653
2022 Q2	$4.9M	Sell	762,616 -5,728	-0.7%	-$36.5K	﹤0.01%	653
2022 Q1	$6.35M	Buy	768,344 +21,230	+3%	+$172K	﹤0.01%	661
2021 Q4	$11.6M	Sell	747,114 -5,499	-0.7%	-$106K	﹤0.01%	651
2021 Q3	$16.9M	Buy	752,613 +266,829	+55%	+$5.6M	0.01%	626
2021 Q2	$9.55M	Sell	485,784 -1,382	-0.3%	-$31.3K	﹤0.01%	676
2021 Q1	$16.3M	Buy	+487,166	New	+$15.9M	0.01%	626